Leptin and adiponectin regulate compensatory beta cell growth in accordance to overweight

Medical Hypotheses

Volumn 68, Issue 5, 2007, Pages 1134-1137

  Huypens, Peter Raymond ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADIPOCYTOKINE; ADIPONECTIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; INCRETIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEASOME; PROTEIN KINASE B; SOMATOMEDIN;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; HUMAN; HUMAN CELL; NEGATIVE FEEDBACK; OBESITY; PANCREAS ISLET BETA CELL; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ADIPONECTIN; ANIMALS; HUMANS; INSULIN-SECRETING CELLS; LEPTIN; MODELS, BIOLOGICAL; OVERWEIGHT;

EID: 33847180179     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.09.046     Document Type: Article

References (36)

1. Bonner-Weir S. Regulation of pancreatic beta-cell mass in vivo. Recent Prog Horm Res 49 (1994) 91-104
2. Montanya E., Nacher V., Biarnes M., and Soler J. Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia and hypertrophy. Diabetes 49 (2000) 1341-1346
3. Withers D.J., Burks D.J., Towery H.H., Altamuro S.L., Flint C.L., and White M.F. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet 23 (1999) 32-40
4. Tuttle R.L., Gill N.S., Pugh W., Lee J.P., Koeberlein B., Furth E.E., et al. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med 7 (2001) 1133-1137
5. Taniguchi C.M., Emanuelli B., and Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Bio 7 (2006) 85-96
6. Rui L., Fisher T.L., Thomas J., and White M.F. Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. J Biol Chem 276 (2001) 40362-40367
7. White M.F. IRS proteins and the common path to diabetes. Am J Physiol-Endoc M 283 (2002) E413-E422
8. Hirashima Y., Tsuruzoe K., Kodama S., Igata M., Toyonaga T., Ueki K., et al. Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway. J Endocrinol 179 (2003) 253-266
9. Briaud I., Dickson L.M., Lingohr M.K., McCuaig J.F., Lawrence J.C., and Rhodes C.J. Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells. J Biol Chem 280 (2005) 2282-2293
10. Liang J., Zubovitz J., Petrocelli T., Kotchetkov R., Connor M.K., Han K., et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8 (2002) 1153-1160
11. Kitamura T., Nakae J., Kitamura Y., Kido Y., Biggs III W.H., Wright C.V., et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110 (2002) 1839-1847
12. Shin I., Yakes F.M., Rojo F., Shin N.Y., Bakin A.V., Baselga J., et al. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8 (2002) 1145-1152
13. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
14. Buteau J., Spatz M.L., and Accili D. Transcription factor Foxo1 mediates glucagon-like peptide-1 effects on pancreatic {beta}-cell mass. Diabetes 55 (2006) 1190-1196
15. Jhala U.S., Canettieri G., Screaton R.A., Kulkarni R.N., Krajewski S., Reed J., et al. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS-2. Genes Dev 17 (2003) 1575-1580
16. Kim S.J., Winter K., Nian C., Tsuneoka M., Koda Y., and McIntosh C.H. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic {beta}-cell survival is dependent upon phosphatidylinositol 3-kinase (pi3k)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J Biol Chem 280 (2005) 22297-22307
17. Buteau J., Roduit R., Susini S., and Prentki M. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (Ins-1)-cells. Diabetologia 42 (1999) 856-864
18. Okuya S., Tanabe K., Tanizawa Y., and Oka Y. Leptin increases the viability of isolated rat pancreatic islets by suppressing apoptosis. Endocrinology 142 (2001) 4827-4830
19. Shimabukuro M., Wang M.Y., Zhou Y.T., Newgard C.B., and Unger R.H. Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. P Natl Acad Sci USA 95 (1998) 9558-9561
20. Uchida T., Nakamura T., Hashimoto N., Matsuda T., Kotani K., Sakaue H., et al. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 11 (2005) 175-182
21. Gorogawa S., Fujitani Y., Kaneto H., Hazama Y., Watada H., Miyamoto Y., et al. Insulin secretory defects and impaired islet architecture in pancreatic beta-cell-specific STAT3 knockout mice. Biochem Bioph Res Co 319 (2004) 1159-1170
22. Velloso L.A., Folli F., Sun X.J., White M.F., Saad M.J., and Kahn C.R. Cross-talk between the insulin and angiotensin signaling systems. P Natl Acad Sci USA 93 (1996) 12490-12495
23. Carvalheira J.B., Ribeiro E.B., Folli F., Velloso L.A., and Saad M.J. Interaction between leptin and insulin signaling pathways differentially affects JAK-STAT and PI 3-kinase-mediated signaling in rat liver. Biol Chem 384 (2003) 151-159
24. Choudhury A.I., Heffron H., Smith M.A., Al-Qassab H., Xu A.W., Selman C., et al. The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest 115 (2005) 940-950
25. Ning K., Miller L.C., Laidlaw H.A., Burgess L.A., Perera N.M., Downes C.P., et al. A novel leptin signalling pathway via PTEN inhibition in hypothalamic cell lines and pancreatic beta-cells. EMBO J 25 (2006) 2377-2387
26. + channels in pancreatic beta-cells. Diabetes 46 (1997) 1087-1093
27. Zhao A.Z., Bornfeldt K.E., and Beavo J.A. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. J Clin Invest 102 (1998) 869-873
28. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8 (2002) 1288-1295
29. Wu X.D., Motoshima H., Mahadev K., Stalker T.J., Scalia R., and Goldstein B.J. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52 (2003) 1355-1363
30. Huypens P., Moens K., Heimberg H., Ling Z., Pipeleers D., and Van de Casteele M. Adiponectin-mediated stimulation of AMP-activated protein kinase (AMPK) in pancreatic beta cells. Life Sci 77 (2005) 1273-1282
31. van de Casteele M., Kefas B.A., Cai Y., Heimberg H., Scott D.K., et al. Prolonged culture in low glucose induces apoptosis of rat pancreatic beta-cells through induction of c-myc. Biochem Bioph Res Co 312 (2003) 937-944
32. Rakatzi I., Mueller H., Ritzeler O., Tennagels N., and Eckel J. Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line Ins-1. Diabetologia 47 (2004) 249-258
33. Staiger K., Stefan N., Staiger H., Brendel M.D., Brandhorst D., Bretzel R.G., et al. Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis. J Clin Endocr Metab 90 (2005) 6707-6713
34. Bolster D.R., Crozier S.J., Kimball S.R., and Jefferson L.S. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 277 (2002) 23977-23980
35. Shaw R.J., Bardeesy N., Manning B.D., Lopez L., Kosmatka M., DePinho R.A., et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6 (2004) 91-99
36. Matsubara M., Maruoka S., and Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 147 (2002) 173-180